Deutsche Bank
CCCC icon

Deutsche Bank’s C4 Therapeutics CCCC Stock Holding History

Deutsche Bank’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$288K Sell
86,457
-12,416
-13% -$46.3K ﹤0.01% 2907
2026
Q2 		$462K Buy
+98,873
New +$338K ﹤0.01% 2820
2025
Q2 		– Sell
-46,225
Closed -$74K – 3626
2025
Q1 		$74K Buy
+46,225
New +$138K ﹤0.01% 3291
2024
Q4 		– Sell
-39,180
Closed -$223K – 3622
2024
Q3 		$223K Buy
39,180
+9,332
+31% +$56.2K ﹤0.01% 2882
2024
Q2 		$138K Buy
+29,848
New +$178K ﹤0.01% 3002
2023
Q2 		– Sell
-25,932
Closed -$81.4K – 3827
2023
Q1 		$81.4K Buy
25,932
+8,162
+46% +$48.1K ﹤0.01% 3412
2022
Q4 		$105K Buy
17,770
+281
+2% +$2.33K ﹤0.01% 3308
2022
Q3 		$153K Sell
17,489
-939
-5% -$9.7K ﹤0.01% 3099
2022
Q2 		$139K Sell
18,428
-8,562
-32% -$75.3K ﹤0.01% 3356
2022
Q1 		$654K Sell
26,990
-29,050
-52% -$705K ﹤0.01% 2593
2021
Q4 		$1.8M Buy
56,040
+31,854
+132% +$1.26M ﹤0.01% 2064
2021
Q3 		$1.08M Buy
24,186
+2,327
+11% +$100K ﹤0.01% 2561
2021
Q2 		$828K Buy
21,859
+14,645
+203% +$525K ﹤0.01% 2893
2021
Q1 		$267K Sell
7,214
-648
-8% -$25.8K ﹤0.01% 3473
2020
Q4 		$260K Buy
+7,862
New +$228K ﹤0.01% 3323

Other funds holding CCCC

Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Vienna Insurance Group
Vienna Insurance Group Warsaw, Poland $466M AUM 97.31% 1-Year Est. Return

Deutsche Bank's CCCC Position: Q3 2026 in Review

Deutsche Bank reduced its C4 Therapeutics (CCCC) stake by 13% in Q3 2026, selling an estimated $46.3K and leaving 86,457 shares worth $288K. The position accounts for ﹤0.01% of the portfolio, ranked #2907.

Deutsche Bank first reported a position in CCCC in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.8M in Q4 2021. 38 funds tracked by Wall St. Rank hold CCCC as of Q3 2026.

  • Deutsche Bank held 86,457 shares of C4 Therapeutics worth $288K as of Q3 2026.
  • Deutsche Bank sold 12,416 C4 Therapeutics shares in Q3 2026, an estimated $46.3K.
  • C4 Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #2907 holding.
  • Deutsche Bank first reported a position in C4 Therapeutics in Q4 2020 and has held it in 15 quarters since.
  • Deutsche Bank's C4 Therapeutics position peaked at $1.8M in Q4 2021.
  • 38 funds tracked by Wall St. Rank held C4 Therapeutics as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.